CC BY-NC-ND 4.0 · Asian J Neurosurg 2020; 15(02): 344-348
DOI: 10.4103/ajns.AJNS_362_19
Original Article

Hearing outcomes after microvascular decompression for hemifacial spasm: An institutional experience

Ambuj Kumar
Department of Neurosurgery, NSCB Government Medical College, Superspeciality Hospital, Jabalpur, Madhya Pradesh
,
Ahmed Ansari
1   Department of Neurosurgery, UPUMS, Etawah, Uttar Pradesh
,
Yasuhiro Yamada
2   Department of Neurosurgery, Fujita Health University Banbuntane Hospital, Nagoya
,
Tsukasa Kawase
2   Department of Neurosurgery, Fujita Health University Banbuntane Hospital, Nagoya
,
Yoko Kato
2   Department of Neurosurgery, Fujita Health University Banbuntane Hospital, Nagoya
› Author Affiliations

Introduction: Hearing loss following microvascular decompression (MVD) for hemifacial spasm is one of the most dreaded complications. Several factors such as stretching of VIII cranial nerve, vasospasm of labyrinthine artery, and acoustic trauma due to drill noise may be considered in its causation. We evaluated the incidence and severity of hearing loss following MVD in hemifacial spasm and the factors which might be responsible for this complication. Methods: A retrospective analysis of 30 patients operated for hemifacial spasm between January 1, 2014, and December 31, 2018, with at least 3 months of follow-up were included in the study. Retromastoid craniotomy was made, and Teflon was placed between involved vessel and VII nerve. Results: Freedom from hemifacial spasm was noted in 27 of 30 patients. Moderate spasm persisted in one patient, which was controlled with medications. The recurrence was noted in 3 patients at 6 months follow-up. Postoperatively, hearing loss was found in one female patient. The offending vessel was both anterior inferior cerebellar artery (AICA) and posterior inferior cerebellar artery (PICA) loop, which was transpositioned during surgery, and the patient was spasm free postoperatively. Conclusion: The incidence of hearing loss following MVD can be minimized using proper surgical techniques and various intraoperative adjuncts such as brainstem auditory evoked responses monitoring, use of endoscope, and indocyanine green or dual-image video angiography.

Financial support and sponsorship

Nil.




Publication History

Received: 15 December 2019

Accepted: 03 January 2020

Article published online:
16 August 2022

© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Wang A, Jankovic J. Hemifacial spasm: Clinical findings and treatment. Muscle Nerve 1998;21:1740-7.
  • 2 Yoshimura DM, Aminoff MJ, Tami TA, Scott AB. Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992;15:1045-9.
  • 3 Barker FG 2nd, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD. Microvascular decompression for hemifacial spasm. J Neurosurg 1995;82:201-10.
  • 4 Dannenbaum M, Lega BC, Suki D, Harper RL, Yoshor D. Microvascular decompression for hemifacial spasm: Long-term results from 114 operations performed without neurophysiological monitoring. J Neurosurg 2008;109:410-5.
  • 5 Yuan Y, Wang Y, Zhang SX, Zhang L, Li R, Guo J. Microvascular decompression in patients with hemifacial spasm: Report of 1200 cases. Chin Med J (Engl) 2005;118:833-6.
  • 6 Lee MH, Jee TK, Lee JA, Park K. Postoperative complications of microvascular decompression for hemifacial spasm: Lessons from experience of 2040 cases. Neurosurg Rev 2016;39:151-8.
  • 7 Ying T, Thirumala P, Gardner P, Habeych M, Crammond D, Balzer J. The Incidence of Early Postoperative Conductive Hearing Loss after Microvascular Decompression of Hemifacial Spasm. J Neurol Surg B Skull Base 2015;76:411-5.
  • 8 Dou NN, Zhong J, Zhou QM, Zhu J, Wang YN, Xia L, et al. The mechanism of hemifacial spasm: A new understanding of the offending artery. Neurol Res 2015;37:184-8.
  • 9 Jannetta PJ. Typical or atypical hemifacial spasm. J Neurosurg 1998;89:346-7.
  • 10 Sindou M, Mercier P. Microvascular decompression for hemifacial spasm: Outcome on spasm and complications. A review. Neurochirurgie 2018;64:106-16.
  • 11 Girard N, Poncet M, Caces F, Tallon Y, Chays A, Martin-Bouyer P, et al. Three-dimensional MRI of hemifacial spasm with surgical correlation. Neuroradiology 1997;39:46-51.
  • 12 Nielsen VK. Electrophysiology of the facial nerve in hemifacial spasm: Ectopic/ephaptic excitation. Muscle Nerve 1985;8:545-55.
  • 13 Yaltho TC, Jankovic J. The many faces of hemifacial spasm: Differential diagnosis of unilateral facial spasms. Mov Disord 2011;26:1582-92.
  • 14 Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1699-706.
  • 15 Jo KW, Kim JW, Kong DS, Hong SH, Park K. The patterns and risk factors of hearing loss following microvascular decompression for hemifacial spasm. Acta Neurochir (Wien) 2011;153:1023-30.
  • 16 Bartindale M, Kircher M, Adams W, Balasubramanian N, Liles J, Bell J, et al. Hearing loss following posterior fossa microvascular decompression: A systematic review. Otolaryngol Head Neck Surg 2018;158:62-75.
  • 17 Miller LE, Miller VM. Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: A systematic review. Br J Neurosurg 2012;26:438-44.
  • 18 Youn J, Kwon S, Kim JS, Jeong H, Park K, Cho JW. Safety and effectiveness of microvascular decompression for the treatment of hemifacial spasm in the elderly. Eur Neurol 2013;70:165-71.
  • 19 Broggi G, Ferroli P, Franzini A, Servello D, Dones I. Microvascular decompression for trigeminal neuralgia: Comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:59-64.
  • 20 Sindou M. Operative strategies for minimizing hearing loss associated with microvascular decompression for trigeminal neuralgia. World Neurosurg 2010;74:111-2.
  • 21 Lee MH, Lee HS, Jee TK, Jo KI, Kong DS, Lee JA, et al. Cerebellar retraction and hearing loss after microvascular decompression for hemifacial spasm. Acta Neurochir (Wien) 2015;157:337-43.
  • 22 Morawski K, Telischi FF, Merchant F, Namyslowski G, Lisowska G, Lonsbury-Martin BL. Preventing internal auditory artery vasospasm using topical papaverine: An animal study. Otol Neurotol 2003;24:918-26.
  • 23 Scavo CG, Roperto R, Cacciotti G, Corrivetti F, Mastronardi L. Prophylactic effect of topical diluted papaverine in preventing hearing loss during microvascular decompression for typical trigeminal neuralgia: Case report and technical note. Interdisciplinary Neurosurg 2019;15:11-4. Available from: http://www.sciencedirect.com/science/article/pii/S2214751918301415. [Last accessed on 2019 Mar 18].
  • 24 Thirumala PD, Carnovale G, Loke Y, Habeych ME, Crammond DJ, Balzer JR, et al. Brainstem auditory evoked potentials' diagnostic accuracy for hearing loss: Systematic review and meta-analysis. J Neurol Surg B Skull Base 2017;78:43-51.
  • 25 Komatsu F, Imai M, Matsumae M. How I do it: Endoscopic microvascular decompression for hemifacial spasm associated with the vertebral artery. Acta Neurochir (Wien) 2018;160:157-9.
  • 26 Zhang H, Fu WM, Chen P, Shi J. Intraoperative indocyanine green angiography during microvascular decompression surgery: Report of 30 cases. Acta Neurochir (Wien) 2014;156:1561-4.